Infographic: Which 3-D Printed Tissues are Closest to the Clinic?

Skin is much easier to create using 3-D printing than intestines.

Written byEmma Yasinski
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Researchers have been using 3-D–printing techniques in hopes of developing tissues that can be transplanted into humans. Some printed tissues, such as skin and bone, are already being tested in humans, while many others are much earlier in development.

Bone ­– Scientists have 3-D printed scaffolding that is seeded with living tissue that grows into bone. While several preclinical trials are underway, one patient with tibial osteomyelitis, an infection that damaged 36 centimeters of his leg bone, successfully received the transplant in 2017 and is now walking. Clinical trials are planned.

Cornea A company called Precise Bio reports it has completed initial safety studies in animals of 3-D printed corneas to treat eye injuries, defects, and infections that cause permanent damage. The company has progressed to further preclinical trials in multiple animal models, and expects to begin clinical trial next year.

Ear – Aurinovo received a rare pediatric disease ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • emma yasinski

    Emma is a Florida-based freelance journalist and regular contributor for The Scientist. A graduate of Boston University’s Science and Medical Journalism Master’s Degree program, Emma has been covering microbiology, molecular biology, neuroscience, health, and anything else that makes her wonder since 2016. She studied neuroscience in college, but even before causing a few mishaps and explosions in the chemistry lab, she knew she preferred a career in scientific reporting to one in scientific research.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies